08 Dec 2008 ERBITUX(R) Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. Food and Drug Administration
08 Dec 2008 ImmunoGen, Inc. Announces Favorable IMGN901 Clinical Findings Reported at ASH Annual Meeting
07 Dec 2008 First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting
06 Dec 2008 Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer
06 Dec 2008 Seattle Genetics Reports Durable Objective Responses with SGN-35 in Lymphoma
06 Dec 2008 Seattle Genetics Reports Objective Responses with Dacetuzumab in Phase II Non-Hodgkin Lymphoma Trial
05 Dec 2008 New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease
05 Dec 2008 YM Biosciences Provides EU Regulatory Update
04 Dec 2008 Roche and FDA Agree on Pathway Towards U.S. Approval of Actemra (tocilizumab)
04 Dec 2008 MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
04 Dec 2008 Symphogen and Meiji Seika Kaisha Ltd. Achieve Milestone in Discovery Collaboration for Recombinant Polyclonal Antibody, Sym006
03 Dec 2008 Conclusion of a joint research agreement between Chiome and Chugai: Innovation in the research and development of therapeutic antibodies by means of the revolutionary "ADLib(R) System" monoclonal antibody identification technology
03 Dec 2008 ProtAb, a Wholly Owned Subsidiary of Hadasit Bio Holdings, Receives U.S. Patent for Proximab for the Treatment of RA and Type-1 Diabetes
02 Dec 2008 Morphotek(R) Inc. Announces Initiation of Farletuzumab Phase II Study In Platinum-Resistant Ovarian Cancer
02 Dec 2008 Innate Pharma Announces The Entry Into Pre-clinical Validation of IPH 4201, a New Monoclonal Antibody Targeting Pancreatic Cancer
02 Dec 2008 UCB announces start of Phase I study for antibody drug candidate CDP6038
01 Dec 2008 FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review
01 Dec 2008 European Commission Approves Erbitux for First-Line Use in Head and Neck Cancer
28 Nov 2008 MedImmune Receives FDA Complete Response Letter on Motavizumab
26 Nov 2008 Arana commences ART621 Phase II rheumatoid arthritis trial
26 Nov 2008 MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone & joint disease
26 Nov 2008 Amorfix Successfully Completes ALS Drug Discovery Program
24 Nov 2008 Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
24 Nov 2008 Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
23 Nov 2008 Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up